ALKS · Company research

Alkermes Inc. plc (ALKS): Valuation Analysis

Available valuation snapshots and ratios; unavailable metrics remain blank.

RESEARCH CONTEXT

Understand the numbers

Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.

1records availableHealthcare

Valuation Analysis data

Database-backed records only

1 rows
valuation datepricemarket capenterprise valuepeforward pepegprice salesprice bookprice fcf
Oct 8, 202641.65$6,743,722,2506232193250.00———23.44867695891792283.728800558458433649.21095944890795916450

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.